BioRestorative Therapies, Inc. (BRTX)

BioRestorative Therapies Statistics

Total Valuation

BRTX has a market cap or net worth of $10.73 million. The enterprise value is -$2.32 million.

Market Cap	10.73M
Enterprise Value	-2.32M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

BRTX has 6.92 million shares outstanding. The number of shares has increased by 74.26% in one year.

Current Share Class	6.92M
Shares Outstanding	6.92M
Shares Change (YoY)	+74.26%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	19.71%
Owned by Institutions (%)	3.93%
Float	4.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	28.39
Forward PS	4.21
PB Ratio	1.07
P/TBV Ratio	1.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.00.

Current Ratio	2.95
Quick Ratio	2.89
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -84.56% and return on invested capital (ROIC) is -65.51%.

Return on Equity (ROE)	-84.56%
Return on Assets (ROA)	-53.24%
Return on Capital (ROIC)	-65.51%
Revenue Per Employee	$34,273
Profits Per Employee	-$877,021
Employee Count	11
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.11% in the last 52 weeks. The beta is 62.36, so BRTX's price volatility has been higher than the market average.

Beta (5Y)	62.36
52-Week Price Change	-17.11%
50-Day Moving Average	1.54
200-Day Moving Average	1.53
Relative Strength Index (RSI)	54.98
Average Volume (20 Days)	101,922

Short Selling Information

The latest short interest is 66,859, so 0.97% of the outstanding shares have been sold short.

Short Interest	66,859
Short Previous Month	74,437
Short % of Shares Out	0.97%
Short % of Float	1.52%
Short Ratio (days to cover)	1.95

Income Statement

In the last 12 months, BRTX had revenue of $377,000 and -$9.65 million in losses. Loss per share was -$1.40.

Revenue	377,000
Gross Profit	352,267
Operating Income	-12.09M
Pretax Income	-6.96M
Net Income	-9.65M
EBITDA	-11.90M
EBIT	-12.09M
Loss Per Share	-$1.40

Balance Sheet

The company has $13.09 million in cash and $42,414 in debt, giving a net cash position of $13.05 million or $1.89 per share.

Cash & Cash Equivalents	13.09M
Total Debt	42,414
Net Cash	13.05M
Net Cash Per Share	$1.89
Equity (Book Value)	9.99M
Book Value Per Share	1.44
Working Capital	8.93M

Cash Flow

In the last 12 months, operating cash flow was -$7.47 million and capital expenditures -$163,779, giving a free cash flow of -$7.63 million.

Operating Cash Flow	-7.47M
Capital Expenditures	-163,779
Free Cash Flow	-7.63M
FCF Per Share	-$1.10

Margins

Gross Margin	93.44%
Operating Margin	-3,205.76%
Pretax Margin	-2,558.95%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-74.26%
Shareholder Yield	-74.26%
Earnings Yield	-89.94%
FCF Yield	-71.18%

Analyst Forecast

The average price target for BRTX is $18.00, which is 1,061.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.00
Price Target Difference	1,061.29%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	244.65%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on October 27, 2021. It was a reverse split with a ratio of 0.00025:1.

Last Split Date	Oct 27, 2021
Split Type	Reverse
Split Ratio	0.00025:1

Scores

BRTX has an Altman Z-Score of -15.51 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-15.51
Piotroski F-Score	2